A prospective phase II study of gefitinib in non-small cell cancer patients with epidermal growth factor receptor gene (EGFR) mutations

被引：0
|
作者：
Sugio, K. [1 ]
Uramoto, H. [1 ]
Oyama, T. [1 ]
Onizuka, T. [1 ]
Ichiki, Y. [1 ]
Yasuda, M. [1 ]
Sugaya, M. [1 ]
Nozoe, T. [1 ]
Takenoyama, M. [1 ]
Hanagiri, T. [1 ]
Yasumoto, K. [1 ]
机构：
[1] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18081
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prospective phase II study of gefitinib in non-small cell lung cancer with epidermal growth factor receptor gene mutations
    Sugio, Kenji
    Uramoto, Hidetaka
    Onitsuka, Takamitsu
    Mizukami, Makiko
    Ichiki, Yoshinobu
    Sugaya, Masakazu
    Yasuda, Manabu
    Takenoyama, Mitsuhiro
    Oyama, Tsunehiro
    Hanagiri, Takeshi
    Yasumoto, Kosei
    [J]. LUNG CANCER, 2009, 64 (03) : 314 - 318
  • [2] Mutations of the epidermal growth factor receptor (EGFR) gene in non-small cell lung cancer (NSCLC).
    Sonobe, M
    Katakura, H
    Adachi, T
    Wada, H
    Tanaka, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 637S - 637S
  • [3] Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations
    Inoue, Akira
    Suzuki, Takuji
    Fukuhara, Tatsuro
    Maemondo, Makoto
    Kimura, Yuichiro
    Morikawa, Naoto
    Watanabe, Hiroshi
    Saijo, Yasuo
    Nukiwa, Toshihiro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (21) : 3340 - 3346
  • [4] Phase II study of gefitinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) gene mutations detected by PNA-LNA PCR clamp.
    Sutani, A.
    Nagai, Y.
    Udagawa, K.
    Uchida, Y.
    Murayama, Y.
    Tanaka, T.
    Miyazawa, H.
    Kanazawa, M.
    Hagiwara, K.
    Kobayashi, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 383S - 383S
  • [5] Gefitinib Therapy in Patients With Advanced Non-Small Cell Lung Cancer With or Without Testing for Epidermal Growth Factor Receptor (EGFR) Mutations
    Wu, Jenn-Yu
    Shih, Jin-Yuan
    Chen, Kuan-Yu
    Yang, Chih-Hsin
    Yu, Chong-Jen
    Yang, Pan-Chyr
    [J]. MEDICINE, 2011, 90 (03) : 159 - 167
  • [6] Mutations in the epidermal growth factor receptor (EGFR): Retro-and prospective observations in non-small cell lung cancer (NSCLC) patients (pts) treated with gefitinib
    Nederlof, R
    Boerrigter, L
    Van 't Veer, L
    Baas, P
    van Zandwijk, N
    [J]. LUNG CANCER, 2005, 49 : S111 - S111
  • [7] A PROSPECTIVE STUDY ON EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS IN NON-SMALL CELL LUNG CANCER IN MALAYSIAN PATIENTS
    Liam, C. K.
    Leow, H. R.
    How, S. H.
    Pang, Y. K.
    Chua, K. T.
    Lai, N. L.
    Lim, B. K.
    Lee, C. H.
    Kuan, Y. C.
    Jayalakshimi, P.
    Pathmanathan, R.
    [J]. RESPIROLOGY, 2012, 17 : 92 - 92
  • [8] Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
    Harrison, Peter T.
    Vyse, Simon
    Huang, Paul H.
    [J]. SEMINARS IN CANCER BIOLOGY, 2020, 61 : 167 - 179
  • [9] Effect of epidermal growth factor receptor gene mutations on adverse events of gefitinib in patients with non-small cell lung cancer.
    Fujiwara, Y
    Kiura, K
    Toyooka, S
    Aoe, M
    Tabata, M
    Hosokawa, S
    Kozuki, T
    Date, H
    Ueoka, H
    Tanimoto, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 644S - 644S
  • [10] Phase II study of the efficacy of gefitinib in patients with non-small cell lung cancer with the EGFR mutations.
    Sunaga, N.
    Yanagitani, N.
    Kaira, K.
    Tomizawa, Y.
    Iijima, H.
    Otani, Y.
    Tanaka, S.
    Suga, T.
    Dobashi, K.
    Mori, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 409S - 409S
12345